Intermittent Fasting: What the Evidence Actually Shows

Intermittent fasting (IF) encompasses a range of eating patterns that cycle between periods of fasting and eating. The most studied protocols include time-restricted eating (TRE, typically an 8 to 10 hour eating window), alternate-day fasting (ADF, alternating normal eating days with very low calorie days), and the 5:2 approach — five days of normal eating and two non-consecutive days of severe calorie restriction. Interest in IF has grown substantially over the past decade, driven by promising animal data and a wave of popular books and media coverage. What does the clinical evidence actually show?

Does intermittent fasting produce more weight loss than continuous calorie restriction?

The short answer is: not consistently. The most rigorous head-to-head comparison to date — a 2022 randomised controlled trial published in the New England Journal of Medicine by Liu and colleagues — assigned 139 participants with obesity to either time-restricted eating (8-hour window) or continuous calorie restriction for 12 months. Both groups lost similar amounts of weight (approximately 8kg), with no significant difference in fat mass, lean mass, blood pressure, or metabolic markers. The authors concluded that TRE offered no advantage over standard calorie restriction when total calorie intake was matched.

A 2020 meta-analysis in Annual Review of Nutrition reached similar conclusions: IF and continuous energy restriction produced equivalent weight loss when compared in controlled trials. The apparent superiority of IF in some studies reflects spontaneous calorie reduction during fasting periods rather than any metabolic advantage of the fasting pattern itself.

Are there benefits beyond weight loss?

Some evidence suggests IF may have metabolic benefits independent of weight loss, though findings are inconsistent. Animal studies show robust effects of fasting on autophagy (cellular repair), insulin sensitivity, and longevity pathways — but these effects are less clearly demonstrated in humans at the fasting durations typically used in IF protocols.

A 2019 study in Cell Metabolism found that time-restricted eating reduced blood pressure, oxidative stress, and insulin resistance in men with metabolic syndrome, even without significant weight loss. However, the study was small and uncontrolled.

Who might benefit from intermittent fasting?

IF may suit people who find it easier to restrict eating to a defined window than to count calories throughout the day. It is not appropriate for everyone — it is contraindicated in pregnancy, in people with a history of eating disorders, in those with type 1 diabetes, and in people taking certain medications that require food. A doctor-led assessment can determine whether IF is a safe and appropriate strategy for your individual circumstances.

For personalised dietary guidance as part of a medically supervised programme, speak to the Weight Loss Wales team.